Bluefin Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-4,908	Closed	-$435K	–	569
2016 Q4	$435K	Buy	4,908 +87	+2%	+$7.92K	0.03%	238
2016 Q3	$465K	Buy	4,821 +660	+16%	+$62.8K	0.02%	197
2016 Q2	$357K	Buy	+4,161	New	+$373K	0.04%	237
2016 Q1	–	Sell	-7,110	Closed	-$802K	–	624
2015 Q4	$802K	Buy	7,110 +1,992	+39%	+$216K	0.09%	258
2015 Q3	$517K	Buy	5,118 +657	+15%	+$78.8K	0.03%	247
2015 Q2	$549K	Buy	4,461 +2,661	+148%	+$319K	0.04%	286
2015 Q1	$206K	Sell	1,800 -6,900	-79%	-$761K	0.02%	379
2014 Q4	$879K	Buy	8,700 +3,222	+59%	+$313K	0.06%	275
2014 Q3	$500K	Buy	5,478 +2,700	+97%	+$237K	0.03%	398
2014 Q2	$200K	Buy	+2,778	New	+$219K	0.01%	608
2013 Q3	–	Sell	-15,954	Closed	-$900K	–	500
2013 Q2	$900K	Buy	+15,954	New	+$922K	0.1%	227